Announced Tue, 21 Jul · 14:35 IST
No investor complaints in Q1 FY27 — PRISM MEDICO AND PHARMACY
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.7%1-day move
₹28.05
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.7-2.1-7.3+3.0+1.2—————
Up moveDown movePending
AI summary
Prism Medico and Pharmacy filed its quarterly investor complaints report under SEBI LODR Regulation 13(3) for the quarter ended 30 June 2026. Zero complaints were pending at the start of the quarter, zero were received, zero were disposed, and zero remained unresolved at the end. The report was submitted jointly with its share registrar, Purva Sharegistry. This is a standard quarterly compliance disclosure, not a one-off event.
Likely market impact
Routine compliance filing with no material effect on the stock. No outstanding complaints is a neutral, housekeeping update.